Skip to main content
YUNGJIN PHARM. CO., LTD logo

YUNGJIN PHARM. CO., LTD — Investor Relations & Filings

Ticker · 003520 ISIN · KR7003520004 KO Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2024-11-28 Regulatory Filings
Country KR South Korea
Listing KO 003520

About YUNGJIN PHARM. CO., LTD

https://eng.yungjin.co.kr/

Yungjin Pharm. Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products for domestic and international markets. The company's portfolio includes a range of prescription drugs, with a focus on areas such as cephalosporin antibiotics and antipsychotic medications. Yungjin Pharm is actively involved in advancing its R&D pipeline, which includes collaborative research for treatments of rare conditions like mitochondrial diseases. Leveraging extensive drug production expertise and R&D capabilities, the company operates as a key affiliate within the KT&G Group's bio/pharmaceutical business.

Recent filings

Filing Released Lang Actions
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Youngjin Pharm, a subsidiary of the KT&G corporate group. It provides specific regulatory disclosures regarding corporate structure, circular shareholding, and inter-company transactions as required by Korean fair trade regulations. Since it is a regulatory disclosure of corporate status and governance details that does not fit into specific financial reporting categories like 10-K or IR, it falls under the general regulatory filing category.
2024-11-28 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Yungjin Pharm Co., Ltd. for the period ending September 30, 2024. It contains detailed financial information, management discussion and analysis, and operational data. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Youngjin Pharm, detailing quarterly financial results (revenue, operating profit, net income) for 2024 Q3. It provides key financial highlights and is explicitly labeled as provisional data. According to the filing definitions, an initial announcement of quarterly financial results is classified as an Earnings Release (ER). Q3 2024
2024-10-31 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Single Sales/Supply Contract' amendment. It details a contract extension for a pharmaceutical supply agreement between Youngjin Pharm and Mylan Seiyaku Ltd. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into the other specialized categories like M&A or Share Issues, it falls under the general regulatory filing category.
2024-10-08 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by Youngjin Pharm. It details the contract value, counterparty, duration, and terms. Since this is a specific regulatory announcement of a material business event (a major supply contract) that does not fit into categories like M&A, dividends, or financial reports, it falls under the 'Regulatory Filings' (RNS) category as the standard fallback for miscellaneous corporate disclosures.
2024-09-10 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings Classification · 100% confidence The document is a 'Corporate Group Status Disclosure' (기업집단현황공시) filed by Youngjin Pharm, a subsidiary of the KT&G corporate group. It provides specific regulatory disclosures regarding group status, circular shareholding, voting rights, and inter-company transactions as required by Korean fair trade regulations. Since it is a regulatory disclosure document that does not fit into specific financial reporting categories like 10-K or IR, and is not merely an announcement of a report, it falls under the general regulatory filing category.
2024-08-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.